Articles related to Pulmonology

Osimertinib plus datopotamab deruxtecan produced 20.5-month median duration of response at the 6 mg/kg dose in EGFR-mutated NSCLC after first-line osimertinib progression in the ORCHARD platform substudy.

Higher Healthy Eating Index scores and elevated oral contraceptive use co-occurred with young-onset lung cancer in a 187-patient nonsmoker cohort presented at AACR.

“Fluvoxamine may have a beneficial role in the clinical management of fatigue in long COVID, although the condition encompasses a broad range of clinical manifestations beyond fatigue alone.” — REVIVE Trial, Annals of Internal Medicine

Investigators surmised that current influenza vaccination programs provide substantial protection but could be further improved by strategies that could mitigate repeat vaccination effects.

“This review aims to inform strategies for early diagnosis, promote rational antibiotic use to mitigate antimicrobial resistance, and guide the development of future therapeutic approaches.” – Lead Author Sebastien Kenmoe, PhD, University of Edinburgh

“Second-line therapy should not be dismissed outright in platinum-refractory or early-relapsing disease. It remains a relevant part of comprehensive care.” — Tingting Tan, MD, PhD, City of Hope